A Phase III, multicenter, randomized, double-masked, sham-controlled study of efficacy and safety of lampalizumab ITV injections administered monthly for 24 months in patients with geographic atrophy secondary to AMD
Basic data for this project
Type of project: Individual project
Duration: since 01/05/2015
Description
Keywords: Klinische Studie; CHROMA
Funding identifier: GX29176 EudraCT 2014-000107-27
Funder / funding scheme:
- Quintiles GmbH
- Roche Pharma AG
Project management at the University of Münster
| Eter, Nicole |
Applicants from the University of Münster
| Eter, Nicole |